Your browser doesn't support javascript.
loading
Coverage determinants of breast cancer screening in Flanders: an evaluation of the past decade.
Ding, L; Jidkova, S; Greuter, M J W; Van Herck, K; Goossens, M; Martens, P; de Bock, G H; Van Hal, G.
Afiliação
  • Ding L; Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Jidkova S; Department of Social Epidemiology and Health Policy, University of Antwerp, Antwerp, Belgium.
  • Greuter MJW; Department of Public Health and Primary Care, Ghent University, Ghent, Belgium.
  • Van Herck K; Center for Cancer Detection, Flanders, Belgium.
  • Goossens M; Department of Radiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Martens P; Department of Robotics and Mechatronics, University of Twente, Enschede, The Netherlands.
  • de Bock GH; Department of Public Health and Primary Care, Ghent University, Ghent, Belgium.
  • Van Hal G; Center for Cancer Detection, Flanders, Belgium.
Int J Equity Health ; 19(1): 212, 2020 11 27.
Article em En | MEDLINE | ID: mdl-33246477
ABSTRACT

BACKGROUND:

Breast cancer (BC) is the most common cancer in women in the developed world. In order to find developing cancers in an early stage, BC screening is commonly used. In Flanders, screening is performed in and outside an organized breast cancer screening program (BCSP). However, the determinants of BC screening coverage for both screening strategies are yet unknown.

OBJECTIVE:

To assess the determinants of BC screening coverage in Flanders.

METHODS:

Reimbursement data were used to attribute a screening status to each woman in the target population for the years 2008-2016. Yearly coverage data were categorized as screening inside or outside BCSP or no screening. Data were clustered by municipality level. A generalized linear equation model was used to assess the determinants of screening type.

RESULTS:

Over all years and municipalities, the median screening coverage rate inside and outside BCSP was 48.40% (IQR 41.50-54.40%) and 14.10% (IQR 9.80-19.80%) respectively. A higher coverage rate outside BSCP was statistically significantly (P < 0.001) associated with more crowded households (OR 3.797, 95% CI 3.199-4.508), younger age, higher population densities (OR 2.528, 95% CI 2.455-2.606), a lower proportion of unemployed job seekers (OR 0.641, 95% CI 0.624-0.658) and lower use of dental care (OR 0.969, 95% CI 0.967-0.972).

CONCLUSION:

Coverage rate of BC screening is not optimal in Flanders. Women with low SES that are characterized by younger age, living in a high population density area, living in crowded households, or having low dental care are less likely to be screened for BC in Flanders. If screened, they are more likely to be screened outside the BCSP.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Detecção Precoce de Câncer País/Região como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Detecção Precoce de Câncer País/Região como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda